- Regulatory Status
- RUO
- Other Names
- IFNL1, Interferon lambda-1, Interleukin-29 (IL-29)
- Ave. Rating
- Submit a Review
- Product Citations
- publications
-
Recombinant Human IFN-λ1 induces cytotoxicity in ICR2a cells (IL28R expressing cells) in a dose-dependent manner. EC50 of this effect is 0.16 – 1.6 ng/mL. -
Stability testing for recombinant Human IFN-λ1. Recombinant Human IFN-λ1 was aliquoted in PBS, pH 7.2, at 0.2 mg/ml and one aliquot was kept at 4°C (Control), and another was frozen and thawed four times (4x Freeze/Thaw). After this procedure, the samples were tested for their ability to induce cytotoxicity in ICR2a cells (IL28R expressing cells) in a dose-dependent manner. EC50 of this effect is 0.16 – 1.6 ng/mL.
| Cat # | Size | Price | Quantity Check Availability | Save | ||
|---|---|---|---|---|---|---|
| 716854 | 25 µg | 220€ | ||||
| 716856 | 100 µg | 796€ | ||||
Interferons (IFNs) are host-encoded secreted proteins which are classified into three types-I, II & III. Type III IFNs, including IFN-λ1/IFN-L1, IFN-λ2/IFN-L2 & IFN-λ3/IFN-L3 are highly similar to each other. IFN-λ proteins are regarded as type-III IFNs because they signal through a receptor complex which is distinct from the receptor used by type-I and type-II IFNs. IFN-λ receptor is expressed preferentially on epithelial-like cells and some immune cells. Type III IFNs play important roles in antiviral immune activities. Type III IFNs (IFN-λ1, 2 & 3) were discovered as interleukin (IL)- 29, 28a & 28b and have many overlapping immune activities with type-I IFNs. In HepG2 cells, recombinant IFN-λ1 & IFN-λ2 restrict the replication levels and cytotoxic activity of herpes simplex virus (HSV). IFN-λ1 & IFN-λ2 can induce the expression of CC chemokines (chemotactic chemokines), which are able to bind to the HIV-1 entry co-receptor CCR5 and restrict the HIV-1 infection of macrophages. IFN-λ plays an important role in the innate immune response in mucosal tissues. A broad spectrum of the antiviral immune activities of IFN-λ have been identified in the liver, lung, brain and intestinal tract.
Product DetailsProduct Details
- Source
- Human IFN-λ1, amino acids Gly20-Thr200 (Accession # Q8IU54), with a Cterminal 6x His tag, was expressed in CHO cells.
- Molecular Mass
- The 190 amino acid recombinant protein has a predicted molecular mass of approximately 21.0 kD. The DTT-reduced and non-reduced protein migrate at approximately 25-35 kD in SDS-PAGE.
-
N-terminal
Sequence Analysis - The predicted N-terminal amino acid is Gly.
- Purity
- > 95%, as determined by Coomassie stained SDS-PAGE.
- Formulation
- 0.22 µm filtered protein solution is in PBS, pH 7.2
- Endotoxin Level
- Less than 0.1 EU per μg of cytokine as determined by the LAL method
- Concentration
- 25 µg size is bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
- Storage & Handling
- Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at – 20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 μg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
- Activity
- Recombinant Human IFN-λ1 induces cytotoxicity in ICR2a cells (IL28R expressing cells) in a dose-dependent manner. EC50 of this effect is 0.16 – 1.6 ng/mL.
- Application
-
Bioassay
- Application Notes
-
BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are validated in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at tech@biolegend.com.
Antigen Details
- Structure
- Monomer
- Function
- Plays roles in antiviral immune responses, induces expression of chemotactic chemokines
- Interaction
- IFN-λ1 targets epithelial cells and hepatocytes, which express the IFN-λ receptor
- Ligand/Receptor
- IFN-λ1 targets epithelial cells and hepatocytes, which express the IFN-λ receptor
- Bioactivity
- Recombinant Human IFN-λ1 induces cytotoxicity in ICR2a cells (IL28R expressing cells) in a dose-dependent manner. EC50 of this effect is 0.16 – 1.6 ng/mL.
- Cell Type
- Epithelial cells, Macrophages
- Biology Area
- Cell Death, Innate Immunity, Signal Transduction
- Molecular Family
- Cytokines/Chemokines, Innate Immune Signaling
- Antigen References
-
- Samuel CE. et al. 2001. Clin Microbiol Rev. 14:778-809.
- Hamana A. et al. 2017. Antiviral Res. 146:130-138.
- Kotenko SV. et al. 2003. Nat Immunol. 4:69-77.
- de Weerd NA and Nguyen T. 2012. Immunol Cell Biol. 90:483-491.
- Hamming OJ. et al. 2013. EMBO J. 32:3055-3065.
- Ank N. et al., 2006. J Virol. 80:4501-4509.
- Hou W. et al., 2009. J Virol. 83:3834-3842.
- Boisvert M. et al., 2016. Front Immunol. 7:628.
- Davidson S. et al., 2016. EMBO Mol Med. 8:1099-1112.
- Lazear HM. et al., 2015. Sci Transl Med. 7:284ra259.
- Lee S and Baldridge MT. 2017. Front Immunol. 8:749.
- Gene ID
- 282618 View all products for this Gene ID
- UniProt
- View information about IFN-lambda1 on UniProt.org
Related FAQs
- Why choose BioLegend recombinant proteins?
-
• Each lot of product is quality-tested for bioactivity as indicated on the data sheet.
• Greater than 95% Purity or higher, tested on every lot of product.
• 100% Satisfaction Guarantee for quality performance, stability, and consistency.
• Ready-to-use liquid format saves time and reduces challenges associated with reconstitution.
• Bulk and customization available. Contact us.
• Learn more about our Recombinant Proteins. - How does the activity of your recombinant proteins compare to competitors?
-
We quality control each and every lot of recombinant protein. Not only do we check its bioactivity, but we also compare it against other commercially available recombinant proteins. We make sure each recombinant protein’s activity is at least as good as or better than the competition’s. In order to provide you with the best possible product, we ensure that our testing process is rigorous and thorough. If you’re curious and eager to make the switch to BioLegend recombinants, contact your sales representative today!
- What is the specific activity or ED50 of my recombinant protein?
-
The specific activity range of the protein is indicated on the product datasheets. Because the exact activity values on a per unit basis can largely fluctuate depending on a number of factors, including the nature of the assay, cell density, age of cells/passage number, culture media used, and end user technique, the specific activity is best defined as a range and we guarantee the specific activity of all our lots will be within the range indicated on the datasheet. Please note this only applies to recombinants labeled for use in bioassays. ELISA standard recombinant proteins are not recommended for bioassay usage as they are not tested for these applications.
- Have your recombinants been tested for stability?
-
Our testing shows that the recombinant proteins are able to withstand room temperature for a week without losing activity. In addition the recombinant proteins were also found to withstand four cycles of freeze and thaw without losing activity.
- Does specific activity of a recombinant protein vary between lots?
-
Specific activity will vary for each lot and for the type of experiment that is done to validate it, but all passed lots will have activity within the established ED50 range for the product and we guarantee that our products will have lot-to-lot consistency. Please conduct an experiment-specific validation to find the optimal ED50 for your system.
- How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?
-
Use formula Specific activity (Units/mg) = 10^6/ ED50 (ng/mL)
Login / Register 



Follow Us